Keywords: بیماری پیشرفته; CI; confidence interval; CR; complete response; DC; disease control; OS; overall survival; PD; progressive disease; PR; partial response; RECIST; Response Evaluation Criteria in Solid Tumors; SD; stable disease; STS; soft tissue sarcoma; TARE; transarteri
مقالات ISI بیماری پیشرفته (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بیماری پیشرفته; metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: بیماری پیشرفته; CR; complete response; DEE; drug-eluting embolic; ÎPBV; change in median parenchymal blood volume; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PBV; parenchymal blood volume; PD; progressive disease; PR;
Keywords: بیماری پیشرفته; Dose titration; Progressive disease; RCC; Targeted therapy; Tyrosine kinase inhibitor;
Keywords: بیماری پیشرفته; BA; bronchial artery; MBC; metastatic breast cancer; PA; pulmonary artery; PD; progressive disease; RR; response rate; SAP-MS; superabsorbent polymer microspheres;
Keywords: بیماری پیشرفته; kidney; carcinoma; renal cell; neoplasm metastasis; interleukin-2; molecular targeted therapy; CR; complete response; ECOG; Eastern Cooperative Oncology Group; HDIL-2; high dose IL-2; IL-2; interleukin-2; mRCC; metastatic RCC; OS; overall survival; PD; pr
Keywords: بیماری پیشرفته; AE; adverse event; AML; acute myeloid leukemia; APC; anaphase promoting complex; CLL; chronic lymphocytic leukemia; CPC; chromosomal passenger complex; CR; complete response; CRi; complete remission with incomplete blood count recovery; FDA; Food and Drug
Keywords: بیماری پیشرفته; Local control; Spine radiosurgery; Spine surgery; Tumor; Wound infection; CT; Computed tomography; CTV; Clinical target volume; DRR; Digitally reconstructed radiograph; ESCC; Epidural spinal cord compression; IM; Infrared markers; MESCC; Metastatic epidur
Keywords: بیماری پیشرفته; Epidermal growth factor receptor-tyrosine kinase inhibitor; Overall survival; Progression-free survival; Progressive disease; Response Evaluation Criteria in Solid Tumors
Keywords: بیماری پیشرفته; CR; complete response; CNR; contrast-to-noise ratio; GIST; gastrointestinal stromal tumor; PD; progressive disease; PDGFRA; platelet-derived growth factor receptor A; PET; positron-emission tomography; PFI; progression-free interval; PR; partial response;
Keywords: بیماری پیشرفته; Cancer; death; demoralization; palliative; progressive disease; psycho-oncology; terminal;
Keywords: بیماری پیشرفته; CR; complete response; EFS; event-free survival; LCR; local control rate; LFU; lost to follow-up; N; number of patients; ORR; overall response rate; OS; overall survival; PD; progressive disease; PNET; primitive neuroectodermal tumor; PR; partial response
Keywords: بیماری پیشرفته; B2M; beta 2 microglobulin; CAR; cyclophophamide, alvocidib, rituximab; CDK; cyclin-dependent kinase; CLL; chronic lymphocytic leukemia; CR; complete response; CRS; cytokine release syndrome; DLT; dose limiting toxicity; ECOG; Eastern Cooperative Oncology
Keywords: بیماری پیشرفته; AJCC; American Joint Committee on Cancer; BMI; body mass index; CR; complete response; CSS; cause-specific survival; EBV; Epstein-Barr virus; FFLF; freedom from local failure; FFDF; freedom from distant failure; GORTEC; Oncology and Radiotherapy Group for
Keywords: بیماری پیشرفته; KZ-syndrome; PTSD; Multimorbidity; Progressive disease; Nazi concentration camp
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: بیماری پیشرفته; ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: بیماری پیشرفته; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: بیماری پیشرفته; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot
Keywords: بیماری پیشرفته; BReC plot; biomarker response characteristic plot; CEA; carcinoembryonic antigen; Cyfra 21.1; cytokeratin 19 fragment; RECIST; response evaluation criteria in solid tumors; CR; complete remission; PR; partial remission; SD; stable disease; PD; progressive
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs
Keywords: بیماری پیشرفته; SSTR; somatostatin receptor; NEN; neuroendocrine neoplasms; SRS; somatostatin receptor scintigraphy; GI; gastrointestinal; GEP; gastroenteropancreatic; NET; neuroendocrine tumor; NEC; neuroendocrine carcinoma; PR; partial response; SD; stable disease; PD;
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
Keywords: بیماری پیشرفته; AE; adverse event; ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; HR; hazar
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study
Keywords: بیماری پیشرفته; Sunitinib; Neuroendocrine tumors; Pancreas; Progressive disease; Target therapy;
Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations
Keywords: بیماری پیشرفته; NSCLC; Non-small cell lung cancer; EGFR; Epidermal growth factor receptor; OS; Overall survival; PD; Progressive disease; PFS; Progression-free survival; Gefitinib; Pemetrexed; EGFR mutation; Beyond progressive disease;
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin
Keywords: بیماری پیشرفته; CI; ConfidenceInterval; CT; ComputedTomography; CTTA; CT-TexturalAnalysis; DCR; Disease Control Rate; DNA; DeoxyribonucleicAcid; FDG-PET; Fludeoxyglucose-Positron Emission Tomography; Fig.; Figure; GIST; Gastrointestinal Stromal Tumor; NGLD; MNeighboring
Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines
Keywords: بیماری پیشرفته; NSCLC; non-small cell lung cancer; PBC; platinum-based chemotherapy; CR; complete response; PR; partial response; NC; no change; SD; stable disease; PD; progressive disease; ORR; objective response rate; DCR; Disease Control Rate; KPS; karnofsky performan
Bispecific antibodies for cancer therapy: A review
Keywords: بیماری پیشرفته; ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas® EGFR mutation test
Keywords: بیماری پیشرفته; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; EGFRm; EGFR mutation-positive; FFPE; formalin-fixed, paraffin-embedded; NSCLC; non-small cell lung cancer; PD; progressive disease; PS; performance status; SD; standard devi
Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer
Keywords: بیماری پیشرفته; FT; tegafur; CDHP; 5-chloro-2,4-dihydroxypyridine; Oxo; potassium oxonate; GI; gastrointestinal; ECOG; Eastern Cooperative Oncology Group; UFT; tegafur uracil; EGFR; epidermal growth factor receptor; BSA; body surface area; PD; progressive disease; CT; co
Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer
Keywords: بیماری پیشرفته; GSTP1; glutathione S-transferase P1; PD; progressive disease; SD; stable disease; PR; partial response; CR; complete response; TSG101; tumour susceptibility gene 101 protein; BCa; breast cancer; microRNA; miRNA; DNA; deoxyribonucleic acid; HSP70; heat sho
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib
Keywords: بیماری پیشرفته; AFP; alpha fetoprotein; CI; confidence interval; DNA; deoxyribonucleic acid; EGF; epidermal growth factor; FGF; fibroblast growth factor; G-CSF; granulocyte colony-stimulating factor; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HR; hazard ratio
The Role of Dual-Phase Cone-Beam CT in Predicting Short-Term Response after Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: بیماری پیشرفته; CI; confidence interval; CR; complete response; HCC; hepatocellular carcinoma; HU; Hounsfield unit; mRECIST; modified Response Evaluation Criteria in Solid Tumors; PD; progressive disease; PR; partial response; ROI; region of interest; SD; stable disease;
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
Keywords: بیماری پیشرفته; EGFR; epidermal growth factor receptor; SFK; Src-family kinase; HNSCC; head and neck squamous cell carcinoma; IL6; interleukin-6; HGF; hepatocyte growth factor; VEGF; vascular endothelial growth factor; IRB; institutional review board; PD; progressive dis
Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT
Keywords: بیماری پیشرفته; CR; complete response; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; mRECIST; Modified Response Evaluation Criteria in Solid Tumors; NET; neuroendocrine tumor; PD; progressive disease; PR; partial response; SD; stable disease; SPECT; single pho
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study
Keywords: بیماری پیشرفته; ALK; Anaplastic Lymphoma Kinase; BMI; body mass index; CCI; Charlson Comorbidity Index; CI; confidence interval; CR; complete response; CRISP; clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patien
Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following
Keywords: بیماری پیشرفته; CR; complete response; EASL; European Association for the Study of the Liver; ICC; intrahepatic cholangiocarcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PD; progressive disease; PR; partial response; RECIST; Response Evaluation
Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis
Keywords: بیماری پیشرفته; BCLC; Barcelona Clinic Liver Cancer; CR; complete response; DEE; drug-eluting embolic; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; IDR; intrahepatic distant recurrence; LTP; local tumor progression; PFS; progression-free survi
Is Fractionated Gamma Knife Radiosurgery a Safe and Effective Treatment Approach for Large-Volume (>10 cm3) Intracranial Meningiomas?
Keywords: بیماری پیشرفته; Fractionation; Gamma Knife radiosurgery; Meningioma; BED; Biologically effective dose; FGKS; Fractionated Gamma Knife radiosurgery; GKS; Gamma Knife radiosurgery; MNG; Meningioma; MRI; Magnetic resonance imaging; PD; Progressive disease; PFS; Progression-
Quantification of Rac1 and Rac1b in serum of non small cell lung cancer by label free real time assay
Keywords: بیماری پیشرفته; NSCLC; Non Small Cell Lung Cancer; pre chemo; pre chemotherapy; Post chemo; post chemotherapy; SPR; surface plasmon resonance; EDC; N-ethyl-Nâ²-3diethylaminopropyl carbodiimide; NHS; N-hydroxysuccinimide; RU; response units; PVDF; polyvinylidene difluori
Combination Therapies in the Management of Large (⥠5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization
Keywords: بیماری پیشرفته; AFP; α-fetoprotein; CR; complete response; MW; microwave; OS; overall survival; PD; progressive disease; PFS; progression-free survival; PR; partial response; RF; radiofrequency;
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
Keywords: بیماری پیشرفته; AE; adverse event; CI; confidence interval; CR; complete response; CT; computed tomography; DCR; disease control rate; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; FAS; full analysis set; HR; hazard ratio; ILD; interst
Sporadic versus Tuberous Sclerosis Complex-Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization
Keywords: بیماری پیشرفته; AML; angiomyolipoma; mTOR; mammalian target of rapamycin; PD; progressive disease; RECIST; Response Evaluation Criteria In Solid Tumors; TSC; tuberous sclerosis complex;
Multidisciplinary effort in treating children with hepatoblastoma in China
Keywords: بیماری پیشرفته; Hepatoblastoma; Pediatrics; Neoadjuvant chemotherapy; Surgery; Multidisciplinary team; AFP; α-fetoprotein; CCCG; Chinese Children's Cancer Group; CHIC; Children's Hepatic tumor International Collaboration; CI; confidence interval; COG; Children's Oncolog
Initial Experience: Alleviation of Pain with Percutaneous CT-Guided Cryoablation for Recurrent Retroperitoneal Soft-Tissue Sarcoma
Keywords: بیماری پیشرفته; CR; complete response; PD; progressive disease; PFS; progression-free survival; PR; partial response; RPS; retroperitoneal soft-tissue sarcoma; RR; response rate; SD; stable disease; VAS; visual analog scale;
The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues
Keywords: بیماری پیشرفته; FFPE; formalin-fixed, paraffin-embedded; RECIST; Response Evaluation Criteria in Solid Tumors Group; HE; hematoxylin and eosin; PR; partial remission; SD; stable disease; PD; progressive disease; miRNA; Drug resistance; Breast cancer; FFPE;
Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
Keywords: بیماری پیشرفته; CR; complete response, EASL = European Association for the Study of the Liver; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; PET; positron emission tomography; PFS; progression
Enhanced therapeutic effect of APAVAC immunotherapy in combination with dose-intense chemotherapy in dogs with advanced indolent B-cell lymphoma
Keywords: بیماری پیشرفته; BM; bone marrow; B-SLL; B-cell small lymphocytic lymphoma; CR; complete remission; DLBCL; diffuse large B-cell lymphoma; DTH; delayed-type hypersensitivity; FC; flow cytometry; FL; follicular lymphoma; HSP; heat shock protein; HSPPC; heat shock protein-pe
Combined Cisplatin-Based Chemoembolization and Radiation Therapy for Hepatocellular Carcinoma Invading the Main Portal Vein
Keywords: بیماری پیشرفته; BCLC; Barcelona Clinic Liver Cancer; CR; complete response; HCC; hepatocellular carcinoma; PD; progressive disease; PR; partial response; PV; portal vein; PVTT; portal vein tumor thrombosis; RT; radiation therapy; SD; stable disease;
Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization
Keywords: بیماری پیشرفته; ADC; apparent diffusion coefficient; AUC; area under the curve; CR; complete response; DEB; drug-eluting bead; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy
Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma
Keywords: بیماری پیشرفته; γ-δ; hematopoietic stem cell transplantation; primary cutaneous γδ T-cell lymphoma; subcutaneous panniculitis-like T-cell lymphoma; T-cell lymphoma; CHOP; cyclophosphamide, Adriamycin, vincristine, prednisone; CHOP-E; cyclophosphamide, Adriamycin, vin
Droplet digital polymerase chain reaction assay for screening of ESR1 mutations in 325 breast cancer specimens
Keywords: بیماری پیشرفته; LBD; ligand-binding domain; ERα; estrogen receptor α; NGS; next generation sequencing; ER+; ER-positive; AIs; aromatase inhibitors; MBC; metastatic breast cancer; ddPCR; droplet digital polymerase chain reaction; FFPE; formalin-fixed paraffin embedded;